NCT05545618

Brief Summary

The effect of brain-heart interaction remains unclear. The study aims to investigate the biological interconnection between brain neural activity and coronary plaque morphological and inflammatory features, as well as their connection with clinical outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
7.7 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

September 19, 2022

Status Verified

September 1, 2022

Enrollment Period

7.8 years

First QC Date

September 15, 2022

Last Update Submit

September 15, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Correlation Between amygdalar activity (neurobiological activity) and bone marrow hematopoiesis (hematopoietic activity)

    Amygdalar target-to-background ratio (TBR) = Amygdalar standardized uptake value (SUV) / Temporal lobe SUV Bone marrow TBR = Bone marrow SUV / Jugular vein SUV Correlation between amygdalar activity (neurobiological activity) and bone marrow hematopoiesis (hematopoietic activity) will be assessed

    at the index imaging

  • Correlation Between amygdalar activity (neurobiological activity) and high-risk plaque

    High-risk plaque features will be assessed by CCTA including positive remodeling (PR, defined as lesion diameter/reference diameter ≥1.1), low attenuation plaque (LAP, defined as a focal central area of plaque with an attenuation density of \<30 Hounsfield Units), spotty calcification (SC, defined as focal calcification within the coronary artery wall \<3mm in maximum diameter), and the "napkin ring" sign (defined as a central area of low attenuation plaque that had a peripheral rim of high attenuation). Correlation Between amygdalar activity and number of high-risk plaque features will be assessed.

    at the index imaging

  • Correlation Between amygdalar activity (neurobiological activity) and coronary inflammation

    Coronary inflammation will be assessed by FAI. Correlation Between amygdalar activity and FAI will be assessed

    at the index imaging

  • Major adverse cardiac events

    Death from coronary heart disease, nonfatal myocardial infarction or hospitalization for unstable angina.

    5 years after index imaging

Secondary Outcomes (1)

  • Cardiovascular death, or nonfatal myocardial infarction

    5 years after index imaging

Study Arms (1)

CCTA imaging with 18F-FDG-PET/CT assessment

Group of patients with 18F-FDG-PET/CT imaging and Coronary Computed Tomographic Angiography within 90 days

Diagnostic Test: CCTA and 18F-FDG-PET/CT

Interventions

18F-FDG-PET/CT imaging and comprehensive assessment of coronary plaque with CCTA within 90 days

CCTA imaging with 18F-FDG-PET/CT assessment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent clinically indicated 18F-FDG PET/CT and with CCTA performed within 90 days of 18F-FDG PET/CT scan will be included.

You may qualify if:

  • \) Age: greater than 20
  • \) Patients either absence of prior cancer or remission from cancer for at least 1 year prior to imaging and throughout the follow-up period;
  • \) Patients absence of acute or chronic inflammatory or autoimmune disease at the time of imaging;
  • \) Patients with CCTA performed within 90 days of 18F-FDG PET/CT scan as part of routine clinical practice
  • \) Patients with diameter stenosis \>30% by CCTA but without coronary revascularization

You may not qualify if:

  • \) Complex coronary lesion (ostial lesion, unprotected left main lesion, chronic total occlusion, grafted vessels, etc)
  • \) Coronary lesion with heavy calcification
  • \) Chronic renal insufficiency (Serum creatinine \>2.0mg/dL)
  • \) Severe liver dysfunction (aspartate transaminase or alanine transferase \> 5 times of upper normal limit)
  • \) Pregnancy or potential pregnancy
  • \) Life expectancy less than 5 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Fuwai Hospital

Beijing, 200000, China

RECRUITING

Shanghai Zhongshan Hospital

Shanghai, 200032, China

RECRUITING

Shanghai Tenth People's Hospital

Shanghai, China

RECRUITING

Universal Medical Imaging Diagnostic

Shanghai, China

RECRUITING

Related Publications (3)

  • Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017 Feb 25;389(10071):834-845. doi: 10.1016/S0140-6736(16)31714-7. Epub 2017 Jan 12.

    PMID: 28088338BACKGROUND
  • Tawakol A, Osborne MT, Wang Y, Hammed B, Tung B, Patrich T, Oberfeld B, Ishai A, Shin LM, Nahrendorf M, Warner ET, Wasfy J, Fayad ZA, Koenen K, Ridker PM, Pitman RK, Armstrong KA. Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease. J Am Coll Cardiol. 2019 Jul 2;73(25):3243-3255. doi: 10.1016/j.jacc.2019.04.042.

    PMID: 31248544BACKGROUND
  • Dai N, Tang X, Weng X, Cai H, Zhuang J, Yang G, Zhou F, Wu P, Liu B, Duan S, Yu Y, Guo W, Ju Z, Zhang L, Wang Z, Wang Y, Lu B, Shi H, Qian J, Ge J. Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity. Circ Cardiovasc Imaging. 2024 Feb;17(2):e016057. doi: 10.1161/CIRCIMAGING.123.016057. Epub 2024 Feb 20.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Junbo Ge, Professor

    Fudan University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2022

First Posted

September 19, 2022

Study Start

January 1, 2015

Primary Completion

October 30, 2022

Study Completion

December 30, 2022

Last Updated

September 19, 2022

Record last verified: 2022-09

Locations